Back to search
FDAFDA · Food and drugs·Recall number D-0377-2022

SENNA Syrup (sennosides) 8.8 mg/ 5 mL unit-dose cups, packaged in 24 cups per carton, Mfg for: AvKARE, TN 38478, NDC 50262-731-24.

Published January 26, 2022 · Recall initiated: December 21, 2021

Summary

FDA records drug Class I recall D-0377-2022, published January 26, 2022 and initiated December 21, 2021. Recalling firm: Lohxa, LLC; Status: Terminated; Reported quantity: 87,840 unit dose cups; Lot: Lot #: AM1115S, Exp. Date 01/2023. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Microbial Contamination of Non-Sterile Product

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Lohxa, LLC
Distributor
Product was distributed to one wholesale who further distributed the product nationwide in the USA
Lot
Lot #: AM1115S, Exp. Date 01/2023
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was SENNA Syrup (sennosides) 8.8 mg/ 5 mL unit-dose cups, packaged in 24 cups per carton, Mfg for: AvKARE, TN 38478, NDC 50262-731-24. recalled?

Yes. FDA published recall D-0377-2022 on January 26, 2022. Reported hazard: Microbial Contamination of Non-Sterile Product

What should I do if I have this product?

Voluntary: Firm initiated · Letter